Vaxart Can't Ditch Claims Co. Lied To Investors About Vaccine
A California federal judge kept alive a proposed securities class action Wednesday claiming the biotechnology company Vaxart pumped up its stock price with deceptive headlines about a COVID-19 vaccine, but tossed...To view the full article, register now.
Already a subscriber? Click here to view full article